Search PubMed⌕ Search

Biomedical subjects

A A Sharp

Publications and source records attributed to A A Sharp.

At least 19 recordsLinked to original sources
PubMed1992

Artificial electrical synapses in oscillatory networks.

1. We use an electronic circuit to artificially electrically couple neurons. 2. Strengthening the coupling between an oscillating neuron and a hyperpolarized, passive neuron can either increase or decrease the frequency of the oscillator depending on the properties of the oscillator. 3. The result of electrically coupling two neuronal oscillators depends on the membrane potentials, intrinsic properties of the neurons, and the coupling strength. 4. The interplay between chemical inhibitory synapses and electrical synapses can be studied by creating both chemical and electrical synapses between two cultured neurons and by artificially strengthening the electrical synapse between the ventricular dilator and one pyloric dilator neuron of the stomatogastric ganglion.

Animals↗
PubMed1977

Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.

Treatment with streptokinase ('Kabikinase') was given to 26 patients with venographically confirmed deep vein thrombosis extending into the popliteal vein or above. Treatment was continued for 4 days and the patients were allocated randomly to oral anticoagulant therapy or a course of treatment with ancrod ('Arvin') for 6 days followed by oral anticoagulant therapy. The degree of thrombolysis as judged by further venographic examination at 10 days was not significantly different between the 2 groups. The majority of patients showed clinical improvement but there was no appreciable difference between the groups at 3 and 6 months. Haemorrhagic complications were a more serious problem during the period of treatment with ancrod than during the equivalent period in the control group.

Ancrod↗
PubMed1974

Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonay embolism.

Treatment with heparin or streptokinase was allocated randomly to 30 patients with life-threatening pulmonary embolism verified by angiography. Treatment was given for 72 hours and pulmonary angiography was repeated. There was significantly greater (P < 0.001) evidence of thrombolysis in those patients treated with streptokinase compared with those treated with heparin. The reduction of systolic and mean pulmonary arterial pressures was also significantly greater (P < 0.05 and P < 0.02 respectively) in the streptokinase group.Seven patients failed to complete 72 hours of the trial treatment: five successfully underwent pulmonary embolectomy. Six of these "failures" had initial pulmonary angiographic scores of 24 or more and systemic systolic blood pressure recordings of 100 mm Hg or less. Patients with these features should probably be considered for pulmonary embolectomy as the initial treatment.A febrile reaction commonly occurred in the streptokinase group; otherwise side effects were no more common than in the heparin group.

Angiography↗
PubMed1972

Coagulometers.

Explore the source record for details and available documents.

Blood Coagulation Tests↗
PubMed1972

Thrombolysis.

Explore the source record for details and available documents.

Adsorption↗